Orthopedics Articles

Orthopedics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Robert R. Recker, et al. - In summary, as this trial was terminated early, there was insufficient power to compare the fracture risks between alendronate and raloxifene. Safety profiles were as expected from clinical trial and post-marketing reports


Previous Article Next Article

Today in Bone Metabolism...keeping you current

Are bisphosphonates effective and safe in patients with low serum vitamin D levels?
International Journal of Clinical Rheumatology, 05/07/09

Prevention of vertebral fractures in osteoporosis: Mixed treatment comparison of bisphosphonate therapies
Current Medical Research and Opinion, 06/23/09

The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women
Osteoporosis International, 05/27/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address